Neonatal Jaundice

Overview

4.7 out of 5 (42 Reviews)

Credits

2.00

Post Assessment Questions

7

Start Date

1 Sep 2023

Last Review Date

12 Feb 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

120 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Neonatal jaundice is a clinical manifestation of elevated total serum bilirubin, termed neonatal hyperbilirubinemia, which results from bilirubin that is deposited into an infant's skin. The characteristic features of neonatal jaundice include yellowish skin, sclerae, and mucous membranes. Neonatal jaundice is usually a mild, transient, and self-limiting condition known as physiologic jaundice. However, this should be distinguished from the more severe pathologic jaundice. The two types of neonatal hyperbilirubinemia are unconjugated hyperbilirubinemia and conjugated hyperbilirubinemia. In most neonates, unconjugated hyperbilirubinemia is the cause of clinical jaundice. However, some infants have conjugated hyperbilirubinemia, which is always pathologic and signifies an underlying medical or surgical etiology. Failure to identify and treat pathologic jaundice may result in bilirubin encephalopathy and associated neurological sequelae.

When neonatal jaundice is clinically identified, the underlying etiology of neonatal hyperbilirubinemia must be determined. Unconjugated hyperbilirubinemia is diagnosed by assessing bilirubin levels with a transcutaneous measurement device or blood samples for total serum bilirubin. Conjugated hyperbilirubinemia is typically diagnosed through laboratory studies, including serum aminotransferase, prothrombin time, urine cultures, tests for inborn errors of metabolism, and, in some cases, imaging studies. Phototherapy and exchange transfusions are the mainstays of treatment of unconjugated hyperbilirubinemia, and a subset of patients also respond to intravenous immunoglobulin (IVIG). Treatment of conjugated hyperbilirubinemia is more complex and depends on the etiology of the jaundice. This activity for healthcare professionals is designed to enhance the learner's competence when managing neonatal jaundice, equipping them with updated knowledge, skills, and strategies for timely identification, effective interventions, and improved interprofessional coordination of care, leading to better patient outcomes and reduced morbidity.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify pathologic jaundice and differentiate it from physiologic jaundice.

  • Delineate the etiologies of neonatal jaundice.

  • Implement evidence-based management options for neonatal jaundice.

  • Identify how the interprofessional team can work collaboratively to prevent the potentially profound complications of neonatal jaundice by applying knowledge about its prevention, presentation, evaluation, and management.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Nurses: StatPearls designates this activity for 2.00 ANCC contact hour(s). Nurses should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the US Food and Drug Administration. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Mark C. on 4/19/2021

Michelle C. on 5/5/2021

Larry M. on 7/20/2021

Maha a. on 8/11/2021

Margarita b. on 2/9/2022

Jennifer K. on 3/8/2022

Beth S. on 4/23/2022

Dr.Ayodhyaprasad S. on 7/6/2022

Prabhat K. on 8/9/2022

mary p. on 11/5/2022

Mary M. on 12/7/2022

lesley b. on 12/20/2022

James M. on 5/9/2023

Ajay P. on 5/16/2023

Gautam P. on 5/22/2023

Brenda B. on 6/25/2023

Morgan F. on 7/18/2023

melanie s. on 8/30/2023

Adithya nikhileshwar B. on 9/26/2023

Debra F. on 9/28/2023

Kenneth K. on 10/10/2023

Brandi H. on 10/12/2023

Blanca G. on 10/19/2023

Akshaya K. on 11/14/2023

Roseann J. on 11/28/2023

Nikki P. on 12/1/2023

RAchel G. on 12/31/2023

Mary S. on 12/31/2023

Ambreen S. on 1/16/2024

Malani K. on 2/29/2024

Paige B. on 3/19/2024

Elaine S. on 4/14/2024

Likta N. on 4/21/2024

Debra M. on 4/24/2024

Katie S. on 8/1/2024

Cameren R. on 8/4/2024

Eric B. on 9/17/2024

Naiomi R. on 9/24/2024

Renee P. on 10/2/2024

Matthew D. on 10/17/2024

Jenny N. on 10/26/2024

Kesendra B. on 10/27/2024

Unlimited Nurse CE

Stay up to date on the latest medical knowledge with 6637 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7883 hours of CE.

Single Activity

Take this single activity

$50 1 activity

6 Month Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$89 per half year per user

1 Year Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$139 per 1 year per user